IRMD (iRadimed Corporation) Stock Analysis - SEC Filings

iRadimed Corporation (IRMD) is a publicly traded Healthcare sector company. As of May 21, 2026, IRMD trades at $90.40 with a market cap of $1.13B and a P/E ratio of 47.84. IRMD moved +1.82% today. Year to date, IRMD is -8.04%; over the trailing twelve months it is +69.64%. Its 52-week range spans $46.86 to $107.90. Analyst consensus is buy with an average price target of $116.00. Rallies surfaces IRMD's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.

Where can I find IRMD SEC filings?

Rallies organizes IRMD SEC filing research, company disclosures, 10-K reports, 10-Q reports, and filing-driven context alongside market data, news, fundamentals, and AI research.

IRMD Key Metrics

Key financial metrics for IRMD
MetricValue
Price$90.40
Market Cap$1.13B
P/E Ratio47.84
EPS$1.86
Dividend Yield0.20%
52-Week High$107.90
52-Week Low$46.86
Volume13
Avg Volume0
Revenue (TTM)$86.28M
Net Income$23.61M
Gross Margin76.83%

Latest IRMD News

Recent IRMD Insider Trades

  • Susi Roger E. sold 653 (~$56.90K) on May 19, 2026.
  • Susi Roger E. sold 1.84K (~$162.27K) on May 19, 2026.
  • Susi Roger E. sold 6 (~$531.9) on May 19, 2026.

IRMD Analyst Consensus

1 analysts cover IRMD: 0 strong buy, 1 buy, 0 hold, 0 sell, 0 strong sell. Consensus rating is buy. Average price target: $116.00.

Common questions about IRMD

Where can I find IRMD SEC filings?
Rallies organizes IRMD SEC filing research, company disclosures, 10-K reports, 10-Q reports, and filing-driven context alongside market data, news, fundamentals, and AI research.
Does Rallies show IRMD 10-K and 10-Q filings?
Rallies organizes IRMD SEC filing research, including 10-K reports, 10-Q reports, company disclosures, and filing-driven context when available.
Is IRMD research on Rallies investment advice?
No. Rallies provides research, data, and educational context for IRMD. It does not provide personalized investment advice.
IRMD

IRMD